Cellular microbiology: Examining the Fic domain.
- Published in:
- Nature Reviews Microbiology, 2009, v. 7, n. 6, p. 405, doi. 10.1038/nrmicro2157
- By:
- Publication type:
- Article
Works matching AU Mullard, Asher
Results: 205
1
2
Prions: Prions hijack the nanotube.
- Published in:
- Nature Reviews Microbiology, 2009, v. 7, n. 4, p. 255, doi. 10.1038/nrmicro2117
- By:
- Publication type:
- Article
3
Infectious Disease: Finding the keys to the placental barrier.
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 11, p. 798, doi. 10.1038/nrmicro2025
- By:
- Publication type:
- Article
4
Environmental Microbiology: Arsenic in action.
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 10, p. 711, doi. 10.1038/nrmicro1995
- By:
- Publication type:
- Article
5
Archaea: Kings of the sea floor?
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 9, p. 648, doi. 10.1038/nrmicro1973
- By:
- Publication type:
- Article
6
HIV: Do the flip.
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 7, p. 500, doi. 10.1038/nrmicro1934
- By:
- Publication type:
- Article
7
DNA replication: Follow the path.
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 6, p. 412, doi. 10.1038/nrmicro1911
- By:
- Publication type:
- Article
8
Immune evasion: Overcoming defensins.
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 6, p. 415, doi. 10.1038/nrmicro1921
- By:
- Publication type:
- Article
9
Metagenomics: Phages apart.
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 4, p. 258, doi. 10.1038/nrmicro1878
- By:
- Publication type:
- Article
10
Symbiosis: Show me the sugar.
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 5, p. 332, doi. 10.1038/nrmicro1908
- By:
- Publication type:
- Article
11
Malaria: Picking Plasmodium falciparum apart.
- Published in:
- Nature Reviews Microbiology, 2008, v. 6, n. 2, p. 95, doi. 10.1038/nrmicro1848
- By:
- Publication type:
- Article
12
Malaria: Sticking around.
- Published in:
- Nature Reviews Microbiology, 2007, v. 5, n. 11, p. 831, doi. 10.1038/nrmicro1785
- By:
- Publication type:
- Article
13
Microbial ecology: Baby boom.
- Published in:
- Nature Reviews Microbiology, 2007, v. 5, n. 9, p. 658, doi. 10.1038/nrmicro1734
- By:
- Publication type:
- Article
14
Viral evolution: As the crow dies.
- Published in:
- Nature Reviews Microbiology, 2007, v. 5, n. 10, p. 746, doi. 10.1038/nrmicro1758
- By:
- Publication type:
- Article
15
Resistance in 18 steps.
- Published in:
- Nature Reviews Microbiology, 2007, v. 5, n. 7, p. 474, doi. 10.1038/nrmicro1695
- By:
- Publication type:
- Article
16
Fitness partners beat the heat.
- Published in:
- Nature Reviews Microbiology, 2007, v. 5, n. 6, p. 396, doi. 10.1038/nrmicro1681z
- By:
- Publication type:
- Article
17
Multicompany trials adapt to disciplines beyond cancer.
- Published in:
- Nature Medicine, 2014, v. 20, n. 1, p. 3, doi. 10.1038/nm0114-3
- By:
- Publication type:
- Article
18
Consumer gene tests poised for regulatory green light.
- Published in:
- Nature Medicine, 2012, v. 18, n. 9, p. 1306, doi. 10.1038/nm0912-1306
- By:
- Publication type:
- Article
19
Next-generation proteasome blockers promise safer cancer therapy.
- Published in:
- Nature Medicine, 2012, v. 18, n. 1, p. 7, doi. 10.1038/nm0112-7a
- By:
- Publication type:
- Article
20
Straight talk with...Phil Willis.
- Published in:
- Nature Medicine, 2011, v. 17, n. 1, p. 11, doi. 10.1038/nm0111-11
- By:
- Publication type:
- Article
21
Straight talk with...Ellen 't Hoen.
- Published in:
- 2010
- By:
- Publication type:
- Interview
22
Straight talk with ... Peter Piot.
- Published in:
- Nature Medicine, 2010, v. 16, n. 8, p. 840, doi. 10.1038/nm0810-840
- By:
- Publication type:
- Article
23
Austerity threatens pharma beyond borders of cost cutters.
- Published in:
- Nature Medicine, 2010, v. 16, n. 7, p. 726, doi. 10.1038/nm0710-726a
- By:
- Publication type:
- Article
24
Straight talk with...Aline Plançon.
- Published in:
- 2010
- By:
- Publication type:
- Interview
25
The anticounterfeiter's technological tool kit.
- Published in:
- Nature Medicine, 2010, v. 16, n. 4, p. 361, doi. 10.1038/nm0410-361a
- By:
- Publication type:
- Article
26
WHO report on drug development marred by big pharma leak.
- Published in:
- Nature Medicine, 2010, v. 16, n. 2, p. 133, doi. 10.1038/nm0210-133
- By:
- Publication type:
- Article
27
Willing subjects live longer but blur clinical trial results.
- Published in:
- Nature Medicine, 2009, v. 15, n. 12, p. 1338, doi. 10.1038/nm1209-1338c
- By:
- Publication type:
- Article
28
Drug makers and NIH team up to find and validate targets.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 241, doi. 10.1038/nrd4293
- By:
- Publication type:
- Article
29
Built-to-buy start-ups begin to bloom.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 161, doi. 10.1038/nrd4258
- By:
- Publication type:
- Article
30
2013 FDA drug approvals.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 2, p. 85, doi. 10.1038/nrd4239
- By:
- Publication type:
- Article
31
2013 in reflection.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 1, p. 5, doi. 10.1038/nrd4218
- By:
- Publication type:
- Article
32
Learning from the 2012-2013 class of breakthrough therapies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 891, doi. 10.1038/nrd4196
- By:
- Publication type:
- Article
33
Make or break for first splice-modulating agents.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 11, p. 813, doi. 10.1038/nrd4151
- By:
- Publication type:
- Article
34
Patient-focused drug development programme takes first steps.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 651, doi. 10.1038/nrd4104
- By:
- Publication type:
- Article
35
David Haslam. Interview by Asher Mullard.
- Published in:
- 2013
- By:
- Publication type:
- Interview
36
David Haslam.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 500, doi. 10.1038/nrd4053
- By:
- Publication type:
- Article
37
New checkpoint inhibitors ride the immunotherapy tsunami.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 489, doi. 10.1038/nrd4066
- By:
- Publication type:
- Article
38
Maturing antibody-drug conjugate pipeline hits 30.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 483, doi. 10.1038/nrd4034
- By:
- Publication type:
- Article
39
Menelas Pangalos.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 418, doi. 10.1038/nrd4044
- By:
- Publication type:
- Article
40
Henry Chesbrough.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 338, doi. 10.1038/nrd4008
- By:
- Publication type:
- Article
41
Maturing antibody-drug conjugate pipeline hits 30.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 329, doi. 10.1038/nrd4009
- By:
- Publication type:
- Article
42
Molecular imaging as a de-risking tool: coming into focus?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 4, p. 251, doi. 10.1038/nrd3993
- By:
- Publication type:
- Article
43
European Lead Factory opens for business.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 173, doi. 10.1038/nrd3956
- By:
- Publication type:
- Article
44
2012 FDA drug approvals.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 87, doi. 10.1038/nrd3946
- By:
- Publication type:
- Article
45
Cholesterol-lowering blockbuster candidates speed into Phase III trials.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 11, p. 817, doi. 10.1038/nrd3879
- By:
- Publication type:
- Article
46
Economists propose a US$30 billion boost to biomedical R&D.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 735, doi. 10.1038/nrd3857
- By:
- Publication type:
- Article
47
PDUFA V goes back to basics.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 730, doi. 10.1038/nrd3824
- By:
- Publication type:
- Article
48
Sting of Alzheimer's failures offset by upcoming prevention trials.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 657, doi. 10.1038/nrd3842
- By:
- Publication type:
- Article
49
PDUFA V goes back to basics.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 586, doi. 10.1038/nrd3819
- By:
- Publication type:
- Article
50
Busy panels recommend Pfizer's tofacitinib, Arena's lorcaserin and more.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 7, p. 579, doi. 10.1038/nrd3778
- By:
- Publication type:
- Article